1. Home
  2. GL vs BMRN Comparison

GL vs BMRN Comparison

Compare GL & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globe Life Inc.

GL

Globe Life Inc.

HOLD

Current Price

$140.09

Market Cap

11.3B

Sector

Finance

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$59.15

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GL
BMRN
Founded
1900
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3B
10.0B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
GL
BMRN
Price
$140.09
$59.15
Analyst Decision
Buy
Buy
Analyst Count
10
19
Target Price
$160.00
$89.74
AVG Volume (30 Days)
489.6K
3.0M
Earning Date
02-04-2026
02-18-2026
Dividend Yield
0.77%
N/A
EPS Growth
16.72
59.53
EPS
13.77
2.68
Revenue
$5,940,974,000.00
$3,094,001,000.00
Revenue This Year
$7.48
$13.35
Revenue Next Year
$5.31
$9.06
P/E Ratio
$10.15
$22.17
Revenue Growth
3.73
12.39
52 Week Low
$109.38
$50.76
52 Week High
$147.83
$73.51

Technical Indicators

Market Signals
Indicator
GL
BMRN
Relative Strength Index (RSI) 52.37 59.45
Support Level $140.58 $58.44
Resistance Level $144.44 $60.58
Average True Range (ATR) 2.32 1.94
MACD -0.12 0.37
Stochastic Oscillator 22.15 62.78

Price Performance

Historical Comparison
GL
BMRN

About GL Globe Life Inc.

Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: